Vanguard lists 0% stake in Lam Research (NASDAQ: LRCX) after realignment
Rhea-AI Filing Summary
Lam Research Corp: The Vanguard Group filed Amendment No. 14 to a Schedule 13G/A reporting that, after an internal realignment, it beneficially owns 0 shares of common stock, representing 0% of the class. The filing states certain Vanguard subsidiaries will report ownership separately in reliance on SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings; reported zero beneficial ownership in Lam Research.
The amendment states The Vanguard Group underwent an internal realignment and that certain subsidiaries will report ownership separately pursuant to SEC Release No. 34-39538. The filing lists 0 shares and 0% ownership for The Vanguard Group itself.
This is an administrative reporting change; cash-flow treatment and subsidiary positions are not described in this excerpt.
Schedule 13G/A amendment documents a reporting structure change, not a market transaction.
The form clarifies that after the internal reorganization, The Vanguard Group, Inc. no longer is deemed to beneficially own the securities held by those subsidiaries. The signature block shows the filing was signed on 03/27/2026 by the Head of Global Fund Administration.
Investors should note this is a disclosure update; the excerpt does not quantify subsidiary holdings or timing of their separate filings.
FAQ
What did The Vanguard Group report for Lam Research (LRCX)?
Will subsidiary holdings be disclosed separately for LRCX?
What is the significance of SEC Release No. 34-39538 in this filing?
Who signed the Schedule 13G/A amendment and when?